136 related articles for article (PubMed ID: 38604610)
1. Complement-mediated thrombotic microangiopathy on a background of Alport syndrome: A case report.
Coorey CP; de Malmanche T; Chou A; Feddersen M
Nephrology (Carlton); 2024 Apr; ():. PubMed ID: 38604610
[TBL] [Abstract][Full Text] [Related]
2. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
[TBL] [Abstract][Full Text] [Related]
3. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
4. Complement-Mediated Thrombotic Microangiopathy in a Patient With Antiphospholipid Syndrome and Anti-glomerular Basement Membrane Antibodies.
Gallant TL; Zheng E; Hobbs AM; Becka AJ; Bertsch RA
Cureus; 2023 Jul; 15(7):e42410. PubMed ID: 37637585
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of renal thrombotic microangiopathy in lupus nephritis.
Song D; Wu LH; Wang FM; Yang XW; Zhu D; Chen M; Yu F; Liu G; Zhao MH
Arthritis Res Ther; 2013 Jan; 15(1):R12. PubMed ID: 23320601
[TBL] [Abstract][Full Text] [Related]
6. A rare case of Alport syndrome, atypical hemolytic uremic syndrome and Pauci-immune crescentic glomerulonephritis.
Tao J; Lieberman J; Lafayette RA; Kambham N
BMC Nephrol; 2018 Dec; 19(1):355. PubMed ID: 30541482
[TBL] [Abstract][Full Text] [Related]
7. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
[TBL] [Abstract][Full Text] [Related]
9. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G; Kissling S; Pantaleo G; Pascual M; Sadallah S; Teta D
BMC Nephrol; 2021 Jul; 22(1):252. PubMed ID: 34229609
[TBL] [Abstract][Full Text] [Related]
10. Acute Pancreatitis: A Rare Cause of Complement-Mediated Thrombotic Microangiopathy.
Livingston J; Dhanesar G
Cureus; 2023 Mar; 15(3):e36896. PubMed ID: 37128526
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
Zhang B; Xing G
Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
[TBL] [Abstract][Full Text] [Related]
12. Renal Thrombotic Microangiopathy: A Review.
Genest DS; Patriquin CJ; Licht C; John R; Reich HN
Am J Kidney Dis; 2023 May; 81(5):591-605. PubMed ID: 36509342
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
[TBL] [Abstract][Full Text] [Related]
14. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
[TBL] [Abstract][Full Text] [Related]
15. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
Page EE; Little DJ; Vesely SK; George JN
Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
[TBL] [Abstract][Full Text] [Related]
16. Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.
Cassol CA; Williams MPA; Caza TN; Rodriguez S
Medicine (Baltimore); 2019 Sep; 98(39):e17148. PubMed ID: 31574818
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
Kotzen ES; Roy S; Jain K
Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
[TBL] [Abstract][Full Text] [Related]
18. An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy.
Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G
Clin Kidney J; 2019 Jun; 12(3):333-337. PubMed ID: 31198225
[TBL] [Abstract][Full Text] [Related]
19. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
[TBL] [Abstract][Full Text] [Related]
20. Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.
Nitzan-Luques A; Slae M; Zugayar D; Dixon BP; Meir K; Volovelsky O
J Nephrol; 2021 Feb; 34(1):241-245. PubMed ID: 32514992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
